Proposals set out in a joint NHS England and NICE consultation outline a new route for MedTech developers to access NHS funding to fast-track clinically and cost-effective products for use by the healthcare system.
The plans will ensure the growing number of game-changing products recommended by NICE can be introduced in the NHS on a large-scale to improve patient outcomes.
The proposals in the consultation document have been developed by NHS England and NICE with input from the Department of Health and Social Care and other partners, including the Office for Life Science (OLS) and the Medicines and Healthcare products Regulatory Agency (MHRA)…
